The founder of Medistem Laboratories, Inc., Neil Riordan was one who identified, very early, the immense promise of stem cell therapies. From that origin, the company’s proprietary patent pending stem cell technology was born.
The Company continues to gain a solid foothold in the Industry. MDSM has been executing its business model through the establishment of international clinics and forging key cooperative relationships with leading academic institutions.
Through licensure of its trade secrets, know-how, and intellectual property, Medistem expects to generate millions in revenue while developing various drug candidates for the U.S marketplace.
Let us hear your thoughts below: